271 related articles for article (PubMed ID: 19405787)
1. Treatment strategies for Legionella infection.
Pedro-Botet ML; Yu VL
Expert Opin Pharmacother; 2009 May; 10(7):1109-21. PubMed ID: 19405787
[TBL] [Abstract][Full Text] [Related]
2. [Treatment for Legionnaires' disease. Macrolides or quinolones?].
Falcó V; Molina I; Juste C; Crespo M; Almirante B; Pigrau C; Ferrer A; Bravo C; Palomar M; Pahissa A
Enferm Infecc Microbiol Clin; 2006; 24(6):360-4. PubMed ID: 16792936
[TBL] [Abstract][Full Text] [Related]
3. Legionella pneumonia in the Niagara Region, Ontario, Canada: a case series.
Cargnelli S; Powis J; Tsang JL
J Med Case Rep; 2016 Dec; 10(1):336. PubMed ID: 27906087
[TBL] [Abstract][Full Text] [Related]
4. An update on Legionella.
Carratalà J; Garcia-Vidal C
Curr Opin Infect Dis; 2010 Apr; 23(2):152-7. PubMed ID: 20051846
[TBL] [Abstract][Full Text] [Related]
5. [Choice of antimicrobial therapy for Legionnella infection].
de Vries PA; van der Werf TS; Manson WL; Zijlstra JG
Ned Tijdschr Geneeskd; 2005 Feb; 149(9):452-7. PubMed ID: 15771338
[TBL] [Abstract][Full Text] [Related]
6. Macrolides versus quinolones in Legionella pneumonia: results from the Community-Acquired Pneumonia Organization international study.
Griffin AT; Peyrani P; Wiemken T; Arnold F
Int J Tuberc Lung Dis; 2010 Apr; 14(4):495-9. PubMed ID: 20202309
[TBL] [Abstract][Full Text] [Related]
7. Treatment of legionnaires' disease.
Klein NC; Cunha BA
Semin Respir Infect; 1998 Jun; 13(2):140-6. PubMed ID: 9643392
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial chemotherapy for legionnaires' disease: a review.
Edelstein PH
Clin Infect Dis; 1995 Dec; 21 Suppl 3():S265-76. PubMed ID: 8749675
[TBL] [Abstract][Full Text] [Related]
9.
Dubois J; Dubois M; Martel JF
Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32094130
[TBL] [Abstract][Full Text] [Related]
10. Legionella: macrolides or quinolones?
Pedro-Botet L; Yu VL
Clin Microbiol Infect; 2006 May; 12 Suppl 3():25-30. PubMed ID: 16669926
[TBL] [Abstract][Full Text] [Related]
11. Current clinical management of Legionnaires' disease.
Garcia-Vidal C; Carratalà J
Expert Rev Anti Infect Ther; 2006 Dec; 4(6):995-1004. PubMed ID: 17181416
[TBL] [Abstract][Full Text] [Related]
12. Role of rifampin-based combination therapy for severe community-acquired Legionella pneumophila pneumonia.
Varner TR; Bookstaver PB; Rudisill CN; Albrecht H
Ann Pharmacother; 2011 Jul; 45(7-8):967-76. PubMed ID: 21775694
[TBL] [Abstract][Full Text] [Related]
13. Review of azithromycin activity against Legionella spp.
Edelstein PH
Pathol Biol (Paris); 1995 Jun; 43(6):569-72. PubMed ID: 8539085
[TBL] [Abstract][Full Text] [Related]
14. BMS-284756 (T-3811ME) a new fluoroquinolone: in vitro activity against Legionella, efficacy in a guinea pig model of L. pneumophila pneumonia and pharmacokinetics in guinea pigs.
Edelstein PH; Shinzato T; Edelstein MA
J Antimicrob Chemother; 2001 Nov; 48(5):667-75. PubMed ID: 11679556
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of macrolides against intracellular Legionella pneumophila.
Segreti J; Meyer P; Kapell K
Diagn Microbiol Infect Dis; 1996 Jul; 25(3):123-6. PubMed ID: 8902407
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of the ketolide HMR 3647 (RU 6647) for Legionella spp., its pharmacokinetics in guinea pigs, and use of the drug to treat guinea pigs with Legionella pneumophila pneumonia.
Edelstein PH; Edelstein MA
Antimicrob Agents Chemother; 1999 Jan; 43(1):90-5. PubMed ID: 9869571
[TBL] [Abstract][Full Text] [Related]
17. Impact of rifampicin addition to clarithromycin in Legionella pneumophila pneumonia.
Grau S; Antonio JM; Ribes E; Salvadó M; Garcés JM; Garau J
Int J Antimicrob Agents; 2006 Sep; 28(3):249-52. PubMed ID: 16870401
[TBL] [Abstract][Full Text] [Related]
18. Legionella pneumonia: the spectrum continues to expand.
Brown RB
Chest; 2004 Jun; 125(6):1979-80. PubMed ID: 15189909
[No Abstract] [Full Text] [Related]
19. Clinical outcomes for hospitalized patients with Legionella pneumonia in the antigenuria era: the influence of levofloxacin therapy.
Mykietiuk A; Carratalà J; Fernández-Sabé N; Dorca J; Verdaguer R; Manresa F; Gudiol F
Clin Infect Dis; 2005 Mar; 40(6):794-9. PubMed ID: 15736010
[TBL] [Abstract][Full Text] [Related]
20. The clinical efficacy of fluoroquinolone and macrolide combination therapy compared with single-agent therapy against community-acquired pneumonia caused by Legionella pneumophila.
Nakamura S; Yanagihara K; Izumikawa K; Seki M; Kakeya H; Yamamoto Y; Senjyu H; Saito A; Kohno S
J Infect; 2009 Sep; 59(3):222-4. PubMed ID: 19592113
[No Abstract] [Full Text] [Related]
[Next] [New Search]
